VThunter
a database for single-cell screening of virus target cells in animal kingdom
Tiger

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Carnivora; Feliformia; Felidae; Pantherinae; Panthera; Panthera tigris,

Latin Name: Panthera tigris altaica

Tested tissues: Heart, Kidney, Liver, Lung, Spleen, PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0023 2021.04 10X Genomics Heart Normal 16479 Link
Vthunter_0024 2021.04 10X Genomics Kidney Normal 3483 Link
Vthunter_0025 2021.04 10X Genomics Liver Normal 10237 Link
Vthunter_0026 2021.04 10X Genomics Lung Normal 14159 Link
Vthunter_0027 2021.04 10X Genomics Spleen Normal 33029 Link
Vthunter_0057 2021.04 iDrop PBMC Normal 4755 Link
Vthunter_100005 2021.05 iDrop PBMC Normal 4755 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Hepacivirus C
Liver-Liver sinusoidal endothelial cells : 98.66% ;
Lung-Ciliated cells : 95.74% ;
Liver-Cholangiocytes : 92.31% ;
Heart-Epicardial cells : 90.74% ;
Spleen-B cells : 89.01% ;
Liver-Liver sinusoidal endothelial cells : 87.50% ;
Spleen-Fibroblast cells : 83.91% ;
Spleen-Neural cells : 83.70% ;
Spleen-B cells : 81.88% ;
Spleen-Natural killer T cells : 77.16% ;
Liver-Liver sinusoidal endothelial cells : 85.27% ;
Liver-Cholangiocytes : 79.49% ;
Lung-ATII : 73.89% ;
Lung-Ciliated cells : 65.11% ;
Liver-Hepatocytes : 56.17% ;
Liver-B cells : 73.16% ;
Heart-Macrophages : 57.94% ;
Severe acute respiratory syndrome coronavirus 2
Lung-ATII : 98.03% ;
Lung-ATI : 89.80% ;
Spleen-Fibroblast cells : 72.58% ;
Lung-Secretory cells : 70.88% ;
Spleen-B cells : 67.58% ;
Dengue virus
Liver-Liver sinusoidal endothelial cells : 97.77% ;
Lung-Ciliated cells : 92.49% ;
Heart-Epicardial cells : 90.74% ;
Lung-ATII : 90.43% ;
Kidney-Podocytes : 86.32% ;
Liver-Liver sinusoidal endothelial cells : 87.50% ;
Spleen-Fibroblast cells : 83.91% ;
Spleen-Neural cells : 83.70% ;
Spleen-B cells : 81.88% ;
Spleen-Natural killer T cells : 77.16% ;
Spleen-Macrophages : 72.92% ;
Spleen-Monocytes : 56.40% ;
Spleen-B cells : 55.47% ;
Lung-Mast cells : 53.97% ;
Sindbis virus
Liver-Liver sinusoidal endothelial cells : 97.77% ;
Lung-Ciliated cells : 92.49% ;
Heart-Epicardial cells : 90.74% ;
Lung-ATII : 90.43% ;
Kidney-Podocytes : 86.32% ;
Adeno-associated virus 9
Liver-Liver sinusoidal endothelial cells : 97.77% ;
Lung-Ciliated cells : 92.49% ;
Heart-Epicardial cells : 90.74% ;
Lung-ATII : 90.43% ;
Kidney-Podocytes : 86.32% ;
Adeno-associated virus - 2
Liver-Liver sinusoidal endothelial cells : 97.77% ;
Lung-Ciliated cells : 92.49% ;
Heart-Epicardial cells : 90.74% ;
Lung-ATII : 90.43% ;
Kidney-Podocytes : 86.32% ;
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Lung-Ciliated cells : 55.58% ;
Adeno-associated virus - 3
Liver-Liver sinusoidal endothelial cells : 97.77% ;
Lung-Ciliated cells : 92.49% ;
Heart-Epicardial cells : 90.74% ;
Lung-ATII : 90.43% ;
Kidney-Podocytes : 86.32% ;
Adeno-associated virus - 8
Liver-Liver sinusoidal endothelial cells : 97.77% ;
Lung-Ciliated cells : 92.49% ;
Heart-Epicardial cells : 90.74% ;
Lung-ATII : 90.43% ;
Kidney-Podocytes : 86.32% ;
Classical swine fever virus
Liver-Liver sinusoidal endothelial cells : 97.77% ;
Lung-Ciliated cells : 92.49% ;
Heart-Epicardial cells : 90.74% ;
Lung-ATII : 90.43% ;
Kidney-Podocytes : 86.32% ;
Venezuelan equine encephalitis virus
Liver-Liver sinusoidal endothelial cells : 97.77% ;
Lung-Ciliated cells : 92.49% ;
Heart-Epicardial cells : 90.74% ;
Lung-ATII : 90.43% ;
Kidney-Podocytes : 86.32% ;
Echovirus E6
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Echovirus E7
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Echovirus E11
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Echovirus E12
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Echovirus E13
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Echovirus E20
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Echovirus E21
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Echovirus E29
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Echovirus E33
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Enterovirus D68
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Coxsackievirus B1
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Lung-ATII : 55.01% ;
Coxsackievirus B3
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Coxsackievirus B5
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Coxsackievirus A21
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Human enterovirus 70
Lung-Ciliated cells : 96.75% ;
Heart-Epicardial cells : 85.19% ;
Lung-Secretory cells : 69.80% ;
Lung-ATII : 62.07% ;
Lung-Macrophages : 60.75% ;
Encephalomyocarditis virus
Spleen-B cells : 95.79% ;
Spleen-Macrophages : 95.44% ;
Spleen-Fibroblast cells : 94.42% ;
Spleen-Natural killer T cells : 94.12% ;
Spleen-Monocytes : 94.01% ;
Simian rotavirus A strain RRV
Lung-Ciliated cells : 93.31% ;
Liver-Liver sinusoidal endothelial cells : 80.36% ;
Lung-ATII : 76.26% ;
Liver-Hepatocytes : 70.34% ;
Spleen-B cells : 69.04% ;
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Liver-Cholangiocytes : 64.10% ;
Liver-Liver sinusoidal endothelial cells : 56.70% ;
Lung-Ciliated cells : 56.59% ;
West Nile virus
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Coxsackievirus A9
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Lung-ATII : 55.01% ;
Human parechovirus 1
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Human mastadenovirus C
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Human betaherpesvirus 5
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Liver-Liver sinusoidal endothelial cells : 85.27% ;
Liver-Cholangiocytes : 79.49% ;
Lung-ATII : 73.89% ;
Lung-Ciliated cells : 65.11% ;
Liver-Hepatocytes : 56.17% ;
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Human alphaherpesvirus 1
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Lung-Ciliated cells : 75.66% ;
Lung-ATII : 55.01% ;
Human gammaherpesvirus 8
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Foot-and-mouth disease virus
Lung-Ciliated cells : 92.90% ;
Liver-B cells : 88.68% ;
Liver-Endothelial cells : 85.05% ;
Liver-Liver sinusoidal endothelial cells : 84.82% ;
Spleen-Macrophages : 81.80% ;
Lung-Ciliated cells : 75.66% ;
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Lung-ATII : 55.01% ;
Influenza A virus
Heart-Epicardial cells : 87.04% ;
Lung-Fibroblasts : 86.56% ;
Heart-Pericytes : 84.85% ;
Heart-Cardiomyocytes : 74.51% ;
Spleen-Natural killer T cells : 63.84% ;
Liver-Liver sinusoidal endothelial cells : 85.27% ;
Liver-Cholangiocytes : 79.49% ;
Lung-ATII : 73.89% ;
Lung-Ciliated cells : 65.11% ;
Liver-Hepatocytes : 56.17% ;
Lung-Ciliated cells : 82.15% ;
Liver-Cholangiocytes : 76.92% ;
Heart-Epicardial cells : 74.07% ;
Liver-Liver sinusoidal endothelial cells : 72.77% ;
Lung-ATII : 72.44% ;
Rhinovirus C
Lung-Ciliated cells : 81.34% ;
Coxsackievirus B2
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Coxsackievirus B4
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Coxsackievirus B6
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Human mastadenovirus A
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Human mastadenovirus D
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Human mastadenovirus E
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Human mastadenovirus F
Lung-ATII : 78.15% ;
Lung-Ciliated cells : 56.19% ;
Ebola virus
Spleen-Macrophages : 76.29% ;
Spleen-B cells : 68.93% ;
Spleen-Fibroblast cells : 63.39% ;
Spleen-Monocytes : 59.13% ;
Liver-Kupffer cells : 58.47% ;
Spleen-Macrophages : 72.92% ;
Spleen-Monocytes : 56.40% ;
Spleen-B cells : 55.47% ;
Lung-Mast cells : 53.97% ;
Liver-Cholangiocytes : 56.41% ;
Marburg marburgvirus
Spleen-Macrophages : 76.29% ;
Spleen-B cells : 68.93% ;
Spleen-Fibroblast cells : 63.39% ;
Spleen-Monocytes : 59.13% ;
Liver-Kupffer cells : 58.47% ;
Spleen-Macrophages : 72.92% ;
Spleen-Monocytes : 56.40% ;
Spleen-B cells : 55.47% ;
Echovirus E1
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Echovirus E8
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Human parvovirus B19
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Human metapneumovirus
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Mammalian orthoreovirus
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Liver-Cholangiocytes : 64.10% ;
Liver-Liver sinusoidal endothelial cells : 56.70% ;
Lung-Ciliated cells : 56.59% ;
Equid alphaherpesvirus 1
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Spleen-Natural killer T cells : 68.69% ;
Spleen-B cells : 67.75% ;
Liver-B cells : 55.00% ;
Human gammaherpesvirus 4
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Spleen-B cells : 65.00% ;
Human rotavirus strain WA
Liver-Cholangiocytes : 74.36% ;
Spleen-B cells : 71.85% ;
Spleen-Macrophages : 67.36% ;
Liver-Liver sinusoidal endothelial cells : 66.52% ;
Spleen-Monocytes : 65.67% ;
Liver-Cholangiocytes : 64.10% ;
Liver-Liver sinusoidal endothelial cells : 56.70% ;
Lung-Ciliated cells : 56.59% ;
Canine parvovirus
Liver-B cells : 73.16% ;
Heart-Macrophages : 57.94% ;
Machupo mammarenavirus
Liver-B cells : 73.16% ;
Heart-Macrophages : 57.94% ;
Guanarito mammarenavirus
Liver-B cells : 73.16% ;
Heart-Macrophages : 57.94% ;
Mouse mammary tumor virus
Liver-B cells : 73.16% ;
Heart-Macrophages : 57.94% ;
Argentinian mammarenavirus
Liver-B cells : 73.16% ;
Heart-Macrophages : 57.94% ;
Feline panleukopenia virus
Liver-B cells : 73.16% ;
Heart-Macrophages : 57.94% ;
Hepatovirus A
Spleen-Macrophages : 72.92% ;
Spleen-Monocytes : 56.40% ;
Spleen-B cells : 55.47% ;
Lung-Mast cells : 53.97% ;
Lassa mammarenavirus
Spleen-Macrophages : 72.92% ;
Spleen-Monocytes : 56.40% ;
Spleen-B cells : 55.47% ;
Lung-Mast cells : 53.97% ;
Lung-ATII : 68.29% ;
Heart-Epicardial cells : 62.96% ;
Liver-Liver sinusoidal endothelial cells : 60.71% ;
Liver-Cholangiocytes : 58.97% ;
Lung-Ciliated cells : 56.80% ;
Human mastadenovirus B
Spleen-Monocytes : 68.66% ;
Lung-Macrophages : 61.47% ;
Spleen-Macrophages : 60.74% ;
Heart-Macrophages : 58.66% ;
Spleen-Monocytes : 64.58% ;
Latino mammarenavirus
Lung-ATII : 68.29% ;
Heart-Epicardial cells : 62.96% ;
Liver-Liver sinusoidal endothelial cells : 60.71% ;
Liver-Cholangiocytes : 58.97% ;
Lung-Ciliated cells : 56.80% ;
Oliveros mammarenavirus
Lung-ATII : 68.29% ;
Heart-Epicardial cells : 62.96% ;
Liver-Liver sinusoidal endothelial cells : 60.71% ;
Liver-Cholangiocytes : 58.97% ;
Lung-Ciliated cells : 56.80% ;
Lymphocytic choriomeningitis mammarenavirus
Lung-ATII : 68.29% ;
Heart-Epicardial cells : 62.96% ;
Liver-Liver sinusoidal endothelial cells : 60.71% ;
Liver-Cholangiocytes : 58.97% ;
Lung-Ciliated cells : 56.80% ;
Coxsackievirus A10
Lung-ATII : 66.47% ;
Feline calicivirus
Liver-Cholangiocytes : 64.10% ;
Liver-Liver sinusoidal endothelial cells : 56.70% ;
Lung-Ciliated cells : 56.59% ;
Polytropic murine leukemia virus
Liver-B cells : 55.26% ;
Xenotropic murine leukemia virus
Liver-B cells : 55.26% ;
Gibbon ape leukemia virus
Heart-Cardiomyocytes : 54.92% ;
Amphotropic murine leukemia virus
Heart-Cardiomyocytes : 54.92% ;
Feline leukemia virus strain B/lambda-B1
Heart-Cardiomyocytes : 54.92% ;
Human papillomavirus type 16
Lung-ATII : 54.53% ;
Varicella Zoster Virus
Liver-Liver sinusoidal endothelial cells : 54.02% ;
Human alphaherpesvirus 3
Liver-Liver sinusoidal endothelial cells : 54.02% ;